background image

Paid Clinical Trials Salt Lake City

Discover 1,149 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Salt Lake City UT, Idaho Falls ID, Fort Collins CO, Albuquerque NMshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Asthma Research Study for Ages 12–17

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

West Jordan UT, Denver CO, Missoula MT, Albuquerque NMshow 70 more

Code:

NCT06307665

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

BDA MDI

AS MDI

Povorcitinib

Recruiting
PHASE3

Sponsor:

Incyte Corporation

Location:

Murray UT, Scottsdale AZ, Phoenix AZ, Sacramento CAshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Nivolumab & Tovorafenib

Recruiting
PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Salt Lake City UT, San Francisco CA, San Diego CA, Minneapolis MNshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

Pegozafermin

Recruiting
PHASE3

Sponsor:

89bio, Inc.

Location:

West Jordan UT, Sandy UT, Las Vegas NV, Littleton COshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

REC-3964

Recruiting
PHASE2

Sponsor:

Recursion Pharmaceuticals Inc.

Location:

Salt Lake City UT, Idaho Falls ID, Phoenix AZ, Sacramento CAshow 7 more

Code:

NCT06536465

Conditions

Recurrent Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

REC-3964

Litifilimab

Recruiting
PHASE2
PHASE3

Sponsor:

Biogen

Location:

Salt Lake City UT, Denver CO, Albuquerque NM, Phoenix AZshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

KC002

Recruiting
PHASE2

Sponsor:

KeraCure

Location:

Bountiful UT, St. George UT, Phoenix AZ, Fresno CAshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Thoracotomy vs. Thoracoscopic

Recruiting
PHASE3

Sponsor:

Children's Oncology Group

Location:

Salt Lake City UT, Boise ID, Las Vegas NV, Henderson NVshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Metformin

Recruiting
PHASE2

Sponsor:

University of Utah

Location:

Salt Lake City UT

Code:

NCT05900466

Conditions

Fibromyalgia Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin

Placebo

IMC-F106C & Checkpoint Inhibitors

Recruiting
PHASE1
PHASE2

Sponsor:

Immunocore Ltd

Location:

Salt Lake City UT, Aurora CO, Sacramento CA, Los Angeles CAshow 18 more

Code:

NCT04262466

Conditions

Select Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brenetafusp

Brenetafusp and pembrolizumab

Brenetafusp and chemotherapy

Brenetafusp and monoclonal antibodies and chemotherapy

Brenetafusp and tebentafusp